Type Multi Risk Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, is pleased to provide an update on the company activities for the quarter ending 30 September 2023. Highlights: Partnership signed with the Gold Coast Private Hospital (a member of Healthscope), to establish a Precision Medicine Clinic at the hospital.GeneType Multi-Test

MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX:GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in guideline-driven genomics-based testing in health, wellness and

The direct-to-consumer genetic testing market is growing at a CAGR of 19.6% from 2022 to 2030....

Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) CEO Simon Morriss tells Proactive the focus over the next 18 months is putting the pathway in...

Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) confirms that its expanded geneType Multi-Risk Test, to include three new diseases —...